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As an essential feature of development, robustness ensures that embryos attain a consistent phenotype despite
genetic and environmental variation. The growing number of examples demonstrating that embryos can mount a
compensatory response to germline mutations in key developmental genes has heightened interest in the phe-
nomenon of embryonic robustness. While considerable progress has been made in elucidating genetic compen-
sation in response to germline mutations, the diversity, mechanisms, and limitations of embryonic robustness
remain unclear. In this work, we have examined whether Xenopus laevis embryos are able to compensate for
perturbations of the Notch signaling pathway induced by RNA injection constructs that either upregulate or
inhibit this signaling pathway. Consistent with earlier studies, we found that at neurula stages, hyperactivation of
the Notch pathway inhibited neural differentiation while inhibition of Notch signaling increases premature dif-
ferentiation as assayed by neural beta tubulin expression. However, surprisingly, by hatching stages, embryos
begin to compensate for these perturbations, and by swimming tadpole stages most embryos exhibited normal
neuronal gene expression. Using cell proliferation and TUNEL assays, we show that the compensatory response is,
in part, mediated by modulating levels of cell proliferation and apoptosis. This work provides an additional model
for addressing the mechanisms of embryonic robustness and of genetic compensation.1. Introduction
While all organisms possess some ability to respond and adapt to
changing genetic and environmental conditions throughout their life-
span, embryonic development is characterized by a particularly
remarkable degree of plasticity (Bateson et al., 2014; Gilbert et al., 2015;
Schwab et al., 2019). Despite phylogenetic differences, embryos typically
display an exceptional robustness allowing them to respond to the
considerable range of perturbations they continually face during devel-
opment yet still achieve a reasonably consistent phenotype. However,
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ture of genetic robustness and the mechanisms underlying the associated
compensatory responses, spurred in part by the observation that phe-
notypes from gene knockdowns frequently display more severe pheno-
types than those associated with mutations in the same gene (El-Brolosy
and Stainier, 2017; Ma et al., 2019; Dooley et al., 2019; El-Brolosy et al.,
2019; Young et al., 2019). This body of work has uncovered novel
mechanisms including the role of mRNA degradation, gene regulatory
network activation of paralogous genes, and growth compensation,
among others.
Despite significant progress and growing interest in addressing this
longstanding issue, our understanding of the robustness and the associ-
ated processes that allow embryos to generate compensatory responses to
perturbations still remains limited (Bateson et al., 2014; Sultan, 2017;
Wu and Belmonte, 2016; Yang et al., 2018; El-Brolosy and Stainier,
2017). Given that many of these recent studies have focused on germline
mutations in genetically tractable organisms, investigation of additional
models and organisms will help to expand our knowledge of the con-
straints and diversity of robustness. For example, in addition to gene
knockdowns and mutations, injection of mRNA overexpression or anti-
morphic constructs are well-established forms of perturbation that can
serve as useful models for understanding robustness (Vize et al., 1991).
While many noteworthy studies have perturbed embryonic develop-
ment by microinjection of gain- and loss-of-function constructs, most
have focused on the relatively immediate effects, specifically the point at
which developmental aberrations appear, with the goal of assessing the
function of given genes. Relatively few of the mRNA injection experi-
ments have specifically examined how embryos respond over more
extended periods of time and assayed for the presence and degree of
robustness, that is, whether the embryo responds with amplifying,
retaining, or compensating for the initial perturbation.
Here, in an effort to develop an additional model system for investi-
gating the phenomenon of embryonic robustness, we asked whether
Xenopus embryos display a compensatory response in the developing
nervous system following perturbation of the Notch signaling pathway, a
highly conserved juxtacrine pathway involved in a wide array of devel-
opmental processes, including early neural development (Chitnis et al.,
1995; Wettstein et al., 1997). We hyperactivated the Notch signaling
pathway with mRNA injections of the intracellular domain (ICD) of
Notch, the region of the protein that once bound to Suppressor of Hairless
translocates to the nucleus to activate new transcription of downstream
effector genes. Notch signaling was downregulated with mRNA in-
jections of a DNA-binding mutant (DBM) of Suppressor of Hairless which,
when overexpressed, sequesters ICD and effectively inhibits downstream
Notch signaling (Chitnis et al., 1995; Wettstein et al., 1997). Using
tubb2b, pcna, and TUNEL to characterize the response, we show that
embryos, over time, exhibit a robust compensatory response at the ge-
netic level to both hyperactivation and downregulation of Notch
signaling, one that employs both differential proliferation as well as
apoptosis of cells in neural regions as likely mechanisms for mediating
this compensatory response.
2. Materials and methods
2.1. Animal use
All animal care and use procedures were performed in accordance
with the regulations set forth by the College of William & Mary Institu-
tional Animal Care and Use Committee (IACUC). Embryos were obtained
by natural mating of adult X. laevis as previously described (Sive et al.,
2007) and were staged according to Nieuwkoop and Faber (1994).
2.2. RNA microinjections
Capped sense RNA was synthesized using the mMessage mMachine
SP6 transcription kit (Ambion) and purified using the RNeasy MinElute100Cleanup kit (Qiagen) according to themanufacturer’s protocol. Injections
were performed in several different ways. For unilateral injections, a
single blastomere was injected at the two-cell stage and embryos were
reared to desired stages (mid-neurula, tailbud, or swimming tadpole). We
performed unilateral injections so that the contralateral side could serve
as an internal negative control, an aspect of Xenopus that is widely
featured in the literature.While Danilchik and Black (1987) reported that
the plane of first cleavage has a random orientation with respect to the
future dorsal midline (Danilchik and Black, 1987), it is generally
accepted that the first cleavage plane does closely correspond to the
future midsaggital axis of the embryo (Klein, 1987; Masho, 1990; Blum
and Ott, 2018; Kha et al., 2018; Lasser et al., 2019; Nenni et al., 2019).
However to ensure that the embryos we injected unilaterally into one
blastomere uniformly labeled only one side of the future embryo, em-
bryos were examined for tracer expression at late gastrula/early neurula
stages, and then again at late neurula, tailbud, or swimming tadpole
stages. In 98% of the cases (n ¼ 1194 embryos from 10 clutches, that is,
different matings), expression was restricted to a single side of the em-
bryo. Any embryo that did not label only one half of the embryo was not
included in our analysis since this would obviously bias the interpreta-
tion of the results. As an additional control, the uninjected side was also
compared to wild type embryos.
For unilateral injections, 4.6 nl of nuclease-free water (NFW) con-
taining 1.5 ng or 0.75 ng of capped transcript encoding either ICD
(Chitnis et al., 1995) or DBM (Wettstein et al., 1997) and 0.5 ng of GFP
(Chalfie et al., 1994) or ß-Galactosidase (Chitnis et al., 1995) as an in-
jection tracer was injected into one side of the embryo. All constructs
were linearized with NotI and transcribed with SP6 RNA polymerase.
Vehicle-injected controls were injected with 4.6 nl NFW containing 0.5
ng of GFP or ß-Galactosidase. For dosage experiments embryos were
unilaterally injected with 3.0 ng of ICD or DBM in 9.2 nl NFW. Bilaterally
injected embryos were injected with 4.6 nl NFW containing either 0.75
ng or 1.5 ng ICD or DBM mRNA and 0.5 ng GFP mRNA into each cell at
the two-cell stage. Control embryos were injected with 1.5 ng of GFP
mRNA on each side to ensure that the GFP mRNA had no effects on
phenotype. ICD and DBM constructs were the kind gifts of C. Kintner.
2.3. Whole-mount in situ hybridization
Antisense RNA probes labeled with either digoxigenin-11 rUTP or
fluorescein-12 rUTP (Roche) were synthesized as described by Sive et al.
(2000) for the following genes: tubb2b (linearized with BamHI,
transcribed with T7) (Klein et al., 2002), sox2 (linearized with EcoRV,
transcribed with T7) (Huyck et al., 2015), and pcna (linearized with XhoI,
transcribed with T7) (Huyck et al., 2015). PCNA in situ hybridization
(ISH) was selected based on reports in the literature suggesting that it
represents an effective and accurate tool for assessing dynamic changes
in proliferation (Muskhelishvili et al., 2003; Kohler et al., 2005).
Whole-mount chromogenic in situ hybridization (ISH) using
nitrobluetetrazolium/5-bromo-4-chloro-3-indolyl phosphate (NBT/
BCIP) alkaline phosphatase substrates was performed as described by
Sive et al. with minor modifications (Sive et al., 2000). Embryos were
photographed using an Olympus SZH10 microscope and an Olympus
DP71 camera or Nikon SMZ800N microscope and Nikon DSi-R2 camera.
Global image adjustments were made using Adobe Photoshop CC to
correct brightness, contrast, and color balance.
2.4. TUNEL assay
Whole-mount terminal deoxynucleotidyl transferase (TdT) dUTP
nick-end labeling (TUNEL) was carried out as described (Hensey and
Gautier, 1998) with minor modifications. Following fixation in MEMFA
(100 mM MOPS pH 7.4, 2 mM EGTA, 1 mM MgSO4, 3.7% (v/v) form-
aldehyde), embryos were rehydrated and permeabilized in PBS with
0.1% Tween-20, equilibrated in TdT buffer (Sigma) at room temperature
(RT), and then incubated overnight in TdT buffer with digoxigenin-11
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in 100 mM EDTA in PBS at 65 C. An alkaline-phosphatase conjugated
anti-dig antibody (Roche) was used with NBT/BCIP color reaction as in
ISH.
2.5. Histology
Following whole-mount assays, embryos were paraffin or cryosec-
tioned as previously described (Pownall and Saha, 2018). Results of
chromogenic assays were photographed using an Olympus BX60 scope
attached to a Media Cybernetics QCapture digital camera. Focusing
specifically on cells within the developing central nervous system, our
analysis consisted of counting the number of cells in neural tissue, as well
as quantifying the number and percentage of both apoptotic and prolif-
erative cells within the neural tube. For every experiment every section of
each embryo (typically 3–4 slides) was analyzed as follows. Neural cells
were quantified by identifying the boundary of the neural tube followed
by counting DAPI-stained nuclei within the boundaries of neural tissue
for every section. Nuclei counting was automated using a custom ImageJ
script (Schneider et al., 2012) (courtesy of Samuel Clamons) based on the
ITCN plug-in (Centre for Bio-Image Informatics, University of California).
Data were normalized to account for variation in embryo size and
sectioning by taking the total number of neural cells for each embryo and
dividing by the number of sections for that embryo. This resulted in an
average number of cells per section for the injected and uninjected sides,
which represents a single data point on the plots in Fig. 4A and B. For the
analysis of apoptotic (using the TUNEL assay) and proliferative (using
PCNA ISH) cells, positive cells were identified by comparison with the
images on the negative control slides; cells were designated as positive if
two double blind evaluators unambiguously identified the cells as
significantly above the background levels of the negative control slides.
All sections were analyzed for each embryo. To normalize for any vari-
ation in embryos, the total number of PCNA or TUNEL-positive cells for
the injected or uninjected side of a single embryo was divided by the total
number of cells in the manually defined neural region of the corre-
sponding injected or uninjected side of that embryo. This resulted in the
fraction of PCNA or TUNEL-positive cells for that embryo; this represents
a single data point in the plots in Fig. 4 C–F. Each data point represents
one side of a single embryo. Statistical significance was determined with
a two-tailed paired t-test to compare the normalized levels of positive
cells in injected and uninjected sides using GraphPad Prism.
2.6. Morphological analysis
We also performed a qualitative morphological assay on the embryos
at tailbud and swimming tadpole stages grouping embryos into normal or
nearly normal (normal touch responsiveness and swimming behavior)
and malformed/unresponsive (abnormal swimming behavior, significant
abnormalities). A two-tailed Fisher’s Exact test in GraphPad was used to
determine statistical significance.
2.7. Real time qRT-PCR
Each sample consisted of five embryos that were flash frozen in liquid
nitrogen and stored in 80 C. Following homogenization in 350 μL TRI
Reagent (Ambion), RNA was extracted with 4-bromoanisole and purified
using the RNeasy Mini Kit (Qiagen). cDNA was synthesized using iScript
Reverse Transcription Supermix for RT-qPCR (BioRad). qRT-PCR was
performed using the TaqMan Gene Expression Master Mix (Life Tech-
nologies) on a StepOne Real-Time PCR System (Applied Biosciences).
Cycling conditions were: 95 C for 10 min; 40 cycles of 95 C for 15 s and
60 C for 1 min. The following primers and probes used:
ICD (50- TCAAGTCCTCCCACGAGTATG -30) and (50- CTGGATC-
TACGTAATACGACTCAC -30) with probe (CAGCCTCAGCGC
ACCCACAT);101DBM (50- TGCAGCAGTAGTGTCCTA -30) and (50- CTGGATCTACG-
TAATACGACTCAC -30) with probe (CATGGAAGGACATGTATAA
CGGACATTTG);
tubb2b (50- GGCAGATTTTCAGACCAGACAACTT -30) and (50-
GACCTTTGGCCCAGTTATTGC -30) with probe (CCACTTTGACCAA
ACACA);
drosha, (50-ACCCCGATCGCCTTCATG-30) and (50-GGCTTTCAAAC
TGCACTTACAGAGA-30) with probe (ACCATCGTTCATCTGCC).
Three biological replicates (with embryos for each replicate obtained
from a separate mating) were each run for each experiment. Additionally,
three technical replicates were run for each RT-PCR sample. Data were
normalized to drosha RNA (ΔΔCT analysis). ICD or DBM conditions were
compared to the GFP control and statistical significance was determined
using a two-tailed t-test in GraphPad Prism.
3. Results
3.1. Following perturbation of the Notch signaling pathway, neuronal
differentiation (tubb2b expression) is initially perturbed but then recovers
In order to determine whether perturbing the Notch signaling
pathway leads to a compensatory response, embryos were injected
unilaterally at the two cell stage with 1.5 ng of the Notch IntraCellular
Domain (ICD) or a DNA Binding Mutant of Suppressor of Hairless (DBM)
RNA to hyperactivate or inhibit the pathway, respectively. The unin-
jected side served as an internal negative control. Embryos were assayed
for expression of Xenopus neural beta tubulin (tubb2b), a pan-neural
marker gene expressed in differentiated neurons (Oschwald et al.,
1991) to assess whether embryos compensated, given that tubb2b gene
expression is highly perturbed at neurula stages as consistently reported
in the literature (Coffman et al., 1993; Ma et al., 1996; Wettstein et al.,
1997). At the neurula stage (stage 18), the relative amount of differen-
tiated neurons detected by tubb2b expression was noticeably lower on the
ICD-injected side in accordance with previously published results
(Fig. 1A, G; Chitnis et al., 1995). DBM-injected embryos show increased
amounts and expanded tubb2b expression on the injected side at the
neurula stage (Fig. 1B, H), also in agreement with previous work
(Wettstein et al., 1997).
Following the effects of these perturbations over time, tubb2b
expression appears to recover as development progresses. Tailbud stage
embryos (stage 28) show an intermediate phenotype, with tubb2b
expression appearing less perturbed than at the neural fold stage, but still
noticeably diminished on the ICD-injected side (Fig. 1C, I), and increased
on the DBM-injected side of embryos (Fig. 1D, J). The differences be-
tween injected and uninjected sides diminish as embryos develop to the
swimming tadpole stage in both ICD- and DBM-injected embryos
(Fig. 1E, F, K–N). In addition to examining tubb2b as a genetic marker, we
also examined embryo morphology. Unlike tubb2b expression which was
remarkably consistent within embryos from a given treatment and stage,
embryos showed more variability and less dramatic compensation at the
level of morphology and swimming behavior. For ICD, 84% of ICD (n ¼
98) embryos at tailbud stages and 82% of the embryos at swimming
tadpole stages (n ¼ 87) were in the normal or nearly normal categories.
At both stages there were statistically significant differences between the
ICD embryos and GFP control embryos (p < 0.05), indicating morpho-
logical compensation is not complete. For DBM, 100% of embryos at
tailbud stages (n ¼ 48) and 98% of the embryos at swimming tadpole
stages (n ¼ 50) were in the normal or nearly normal categories.
Morphologically there was no difference between DBM and GFP injected
controls. There were no statistically significant differences over time
between tailbud and swimming tadpole stages for either ICD or DBM,
suggesting that morphological compensation, to the extent that it occurs,
is complete by late tailbud stages.
To investigate the apparent recovery of tubb2b expression quantita-
tively, expression was assayed at three developmental stages using qRT-
Fig. 1. tubb2b expression in response to
Notch perturbation. Embryos unilaterally
injected with 1.5 ng ICD or DBM show per-
turbed expression of tubb2b at neurula stages
on the injected (left) side (A, B, G, H). The
difference in expression between sides is less
stark at the tailbud stage (C, D, I, J), and
minimal difference between sides is apparent
at the swimming tadpole stage (E, F, K–N).
All embryos shown are left-side injected.
Histological analysis of tubb2b expression in
Notch perturbed embryos supports whole-
mount findings (G-N). Abbreviations: l,
lateral longitudinal stripe of primary neuro-
genesis; i/m, intermediate/medial longitu-
dinal stripes of primary neurogenesis; asc,
anterior spinal cord; e, eye; fb, forebrain; hb,
hindbrain; mb, midbrain; sc, spinal cord; V,
cranial nerve V; IX, cranial nerve IX; X, cra-
nial nerve X. For each stage and each con-
dition, N ¼ >100 for whole mount embryos
and >15 for histological analyses.
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expression is significantly diminished in ICD-injected embryos while
expression is significantly increased in DBM-injected embryos, both with
respect to GFP-injected controls (Fig. 2A). Similar results are seen at the
tailbud stage (stage 28), however the difference in tubb2b expression
between Notch signaling-perturbed and control embryos is diminished
(Fig. 2B). Finally, at swimming tadpole stages (stage 38), there is no
statistically significant difference in tubb2b expression levels between
ICD-injected embryos, DBM-injected embryos, and GFP-injected control
embryos (Fig. 2C). These results quantitatively support the in situ hy-
bridization results showing that terminal neuronal differentiation is
initially perturbed by ICD or DBM injection, but embryos compensate
over time.
To assess the amount of ICD or DBM RNA present in the embryo, qRT-
PCR was performed with construct-specific primers and probes. While
our experiment was designed to test the effects of a relatively acute
perturbation of the Notch signaling system, with diminishing amounts of
remaining construct as development proceeds, both DBM and ICD RNA
are detectable even at stage 40 (Fig. 2D and E). Although significantly
reduced, particularly in light of increased cell number, these results show
that the embryos not only recover from the initial bolus rather than
amplifying the initial effect, but can do so even in the presence of small
amounts of the injected construct.3.2. Bilateral perturbations and higher doses demonstrate limits to
compensatory abilities
Before further investigating the nature of this compensatory response,
we wished to ensure that we were using a sufficiently high dose to test the
limits of the compensatory response. Althoughwe employed a dose at the
high end of those cited in the published literature (which are typically 
1 ng of ICD or DBM RNA; Chitnis et al., 1995; Coffman et al., 1993;102Deblandre et al., 1999, 2001; Ma et al., 1996; Moore et al., 2018; Wett-
stein et al., 1997; Yan et al., 2009a), we nevertheless tested unilateral
injections of the two experimental constructs at a dose of 3.0 ng of ICD
and DBM which resulted in poor survival and a lack of compensatory
response (data not shown).
Although it was important for purposes of data analysis to use the
uninjected side of the embryo serve as an internal control for potential
embryo or experimental variability, we also performed bilateral in-
jections of each construct to determine if embryos would show a similar
compensatory response when injected on both sides. For ICD, embryos
injected with 1.5 ng on both sides showed poor survival and morphology
with only 3% of the embryos displaying normal or near normal
morphology at both tailbud and swimming tadpole stages, a statistically
significant difference between unilateral and bilateral embryos (n¼ 248,
p < 0.001) and between ICD embryos and GFP or wild type controls (n¼
>100 for all controls, p < 0.001, Fig. 3G-I, M-R). Even when 0.75 ng was
injected on each side (the same total amount of RNA as for the unilateral
injection), survival remained poor with only 9% of the embryos dis-
playing normal or near normal morphology at both tailbud and swim-
ming tadpole stages, a statistically significant difference between
unilateral and bilateral embryos (n ¼ 266, p < 0.001) and GFP or wild
type controls (n¼ >100 for all controls, p < 0.001, Fig. 3A–C, M-R). ICD
bilaterally injected embryos show very little tubb2b expression at the
neurula stage (Fig. 3A,G) when compared to GFP bilaterally-injected or
uninjected wild type control embryos (Fig. 3M, P). They show severe
neural tube defects by the tailbud stage (Fig. 3B, H) which are not
observed in GFP bilaterally-injected or uninjected wild type control
embryos (Fig. 3M-R). Few embryos ever survived to the swimming
tadpole stage, showing that embryos bilaterally injected with ICD are not
able to compensate in the same manner as ICD unilaterally injected
embryos (Fig. 3C,I), suggesting a clear limit to the compensatory abilities
of embryos following Notch hyperactivation. Interestingly, DBM
Fig. 2. Quantification of tubb2b expression and construct persistence. qRT-PCR confirms that ICD injected embryos express less tubb2b, while DBM injected
embryos express more tubb2b at the neurula stage (A). tubb2b expression remains perturbed at the tailbud stage (B), but at the swimming tadpole stage, no difference in
expression level is detected when comparing perturbed embryos to vehicle-injected controls (n ¼ 3) (C). qRT-PCR shows that while ICD (D) (n ¼ 3) and DBM (E) (n ¼
3) mRNAs degrade over time, both are still detectable throughout the swimming tadpole stages. Bars represent mean  SEM. * ¼ p < 0.05, ** ¼ p < 0.01.
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response similar to that observed in unilaterally injected embryos. At the
neurula stage, DBM bilaterally injected embryos expectedly show ectopic
tubb2b expression and an expansion of the intermediate/medial longi-
tudinal stripes of primary neurogenesis (Fig. 3D,J). Expanded tubb2b
expression is also observed at the tailbud stage (Fig. 3E, K), but by the
swimming tadpole stage, tubb2b expression appears nearly normal
(Fig. 3F,L) when compared to GFP bilaterally injected or uninjected wild
type control embryos (Fig. 3O, R).
These data suggest a limit to the embryo’s ability to mount an
effective compensatory response, although there are some clear differ-
ences between ICD- and DBM-injected embryos. For subsequent analysis
of the compensatory response we used the unilateral injection regimen
and maximum dose (1.5 ng) reported in the published literature, a dose
for which we observed consistent compensation as assayed by tubb2b
expression.3.3. Initial increase in neuronal cell number following Notch
hyperactivation diminishes by swimming tadpole stages
In order to characterize the nature of the compensatory response we
asked whether there were significant changes in cell number in the
neural plate/tube by quantifying the number of cells in the anatomically
defined neural region in perturbed and unperturbed sides of experi-
mental embryos. Embryos injected with DBM do not show statistically
significant differences in the total number of neuronal cells between the
injected and uninjected side at any stage measured (Fig. 4B). However,
embryos injected with ICD have significantly more neuronal cells on the
perturbed side compared to the internal control side at neurula through
early swimming tadpole stages (stages 15, 25, 30, 35) (Fig. 4A). ICD-
injected embryos show no significant difference between perturbed103and unperturbed sides at later swimming tadpole stages (stage 40).
3.4. Effects of Notch perturbation on apoptosis
In order to assess whether apoptosis contributed to the compensatory
changes in neuronal cell number we analyzed the proportion of apoptotic
cells on the injected and uninjected sides of Notch-perturbed embryos
using a TUNEL assay (Hensey and Gautier, 1998), (Fig. 4). Embryos
injected with ICD have significantly higher proportions of TUNEL posi-
tive cells on the injected side when compared to the uninjected side at
stage 35 (Fig. 4C) suggesting a compensatory response to equalize cell
numbers. Expectedly, DBM injected embryos displayed no significant
differences in the proportion of apoptotic cells when comparing the
injected and uninjected side (Fig. 4D). Representative histological sec-
tions are shown in Fig. 4G.
3.5. Effects of Notch perturbation on cell proliferation
Given the changes in cell number observed for ICD injections and the
known interaction between Notch signaling and cell proliferation, we
also assayed whether differential cell proliferation dynamics could ac-
count for the equalizing neuronal cell number between the injected and
uninjected sides. To assess both the effects of Notch perturbation on cell
proliferation and its role in the compensatory response, the proportion of
proliferative cells to total cells was quantified in the injected and unin-
jected sides of Notch perturbed embryos using pcna, a transcript
expressed in proliferating cells that encodes a DNA clamp required for
DNA replication (Wullimann et al., 2005) (Fig. 4). Embryos unilaterally
injected with ICD show a significantly lower proportion of pcna positive
cells on the injected side when compared to the uninjected side at stage
30 (Fig. 4E) suggesting a compensatory response to equalize cell number.
Fig. 3. tubb2b expression in bilaterally
perturbed embryos. Embryos were bilater-
ally injected at the two-cell stage with either
ICD (A-C, G-I) or DBM (D-F, J-L) mRNA and
reared to desired stages. ICD bilaterally
injected embryos demonstrate minimal
tubb2b expression at the neurula stage (A,G,
arrowhead) and show morphological defects
by the tailbud stage (B,H, arrowhead). DBM
bilaterally injected embryos show ectopic
tubb2b expression at the neurula stage (D,J,
arrowhead), but appear to compensate in a
gradual manner over time (E-F, K-L). GFP
bilaterally injected embryos and wild type
remain unperturbed (M-R). Abbreviations: i/
m, intermediate/medial longitudinal stripes
of primary neurogenesis; fb, forebrain; mb,
midbrain; hb, hindbrain; e, eye; sc, spinal
cord. For each stage, N ¼ >50 for ICD and
GFP, >10 for DBM. Embryos were obtained
from a minimum of three different clutches.
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cantly lower proportion of pcna positive cells on the injected side when
compared to the uninjected side at stages 15, 30, and 35 (Fig. 4F) though
this does not result in changes of cell numbers. Representative histo-
logical sections are shown in Fig. 4H.
4. Discussion
Robustness, the ability of organisms to respond to variations in
genotypic and environmental backgrounds yet maintain similar pheno-
typic outcomes, is of fundamental importance for ensuring proper
development given the wide range of perturbations embryos continually
experience. While the particular ability of embryos to compensate for a
wide range of perturbations has long been appreciated, the diversity,
limitations, and mechanisms governing robustness have remained un-
clear (El-Brolosy and Stainier, 2017). Recently, however, there has been
a renewed interest in the phenomenon of robustness in order to explain a
growing number of instances in which a gene knockdown shows a severe
phenotype while a mutation in the same gene shows a milder phenotype,
suggesting genetic compensation in the latter case (Housden et al., 2016;
Rossi et al., 2015). Recent work has shown that genetic compensation
occurs in mutations generating premature termination codons by trig-
gering nonsense-induced mRNA degradation and subsequent transcrip-
tional compensation (El-Brolosy et al., 2019; Ma et al., 2019).
Compensatory responses for mutations in other genes have shown
different mechanisms of compensation, including the activation of a gene104regulatory network based on a homologous/paralogous gene, and
compensatory growth (Dooley et al., 2019; Ma et al., 2019).
These recent studies have largely focused on germline mutations,
however there are a range of other types of perturbations that may
contribute to our understanding of compensatory responses including
mRNA constructs that perturb gene regulatory networks through a va-
riety/range of mechanisms including overexpression and inhibition.
Unlike germline mutations or continual exposure to a toxin, these per-
turbations are more transient in nature, due to ongoing degradation of
the construct and dilution of injected mRNA due to cell division. How-
ever, this type of perturbation is of considerable interest for analysis of
robustness. As in the case of Notch signaling perturbation, there is a
dramatic alteration of both gene expression and neural plate
morphology, and a subsequent compensatory response that allows the
embryo to recover, although it should be noted that morphological
compensation is not complete as we have shown through this work.
Here we have demonstrated a compensatory response over time to
transient perturbations of Notch signaling in X. laevis embryos using two
different injected RNA constructs, ICD and DBM, which, respectively,
overexpress and inhibit Notch signaling. Many previous studies have
perturbed Notch signaling to determine its role in development and our
results are fully consistent with those of other studies at the early stages
of development (Chitnis et al., 1995; Coffman et al., 1993; Ma et al.,
1996; Wettstein et al., 1997; Deblandre et al., 1999, 2001; Lamar et al.,
2001; Moore et al., 2018; Riddiford and Schlosser, 2017; Yan et al.,
2009a). At neurula and tailbud stages, we observed decreased expression
Fig. 4. Apoptosis and proliferation in response to Notch perturbation. Total number of neural cells were measured in injected and uninjected sides of embryos
over time in response to ICD injection (A) and DBM injection (B) (n ¼ 10; * ¼ p  0.05). Subsequently, the proportion of cells positive for TUNEL staining was
measured on the injected (I) and uninjected (U) sides (C, D) (n ¼ 5; * ¼ p  0.05, ** ¼ p  0.01 *** ¼ p  0.001). Next, the proportion of neural cell expressing pcna
was measured in injected and uninjected sides of embryos (E, F) (n ¼ 5; * ¼ p  0.05). Representative images of TUNEL staining and pcna expression in Notch
perturbed embryos are shown in G and H, respectively. All embryos shown are left-side injected. Abbreviations: np, neural plate; nc, notochord; fb, forebrain; hb,
hindbrain; mb, midbrain; e, eye; ot, otic vesicle.
G.E. Solini et al. Developmental Biology 460 (2020) 99–107of tubb2b in embryos with hyper-activated Notch, and increased ectopic
expression of tubb2b in embryos with Notch signaling inhibited. How-
ever, relatively few studies have followed the embryos throughout
development, leaving the question of whether there is an eventual
compensatory response unanswered.
We addressed this by assessing the response of embryos to Notch
perturbation through the swimming tadpole stage. Others have shown
genetic perturbations may change in their effect over time (Riddiford and
Schlosser, 2017; Schlosser et al., 2008; Yan et al., 2009b), while some
studies have reported that perturbations can persist until the swimming
tadpole stages (Ochi et al., 2017; Vandenberg et al., 2012) or even
through froglet stages (Jevtic et al., 2019) following RNA injection at
early stages of development. Our results demonstrate a compensatory
response by the swimming tadpole stage in both up-regulation and
down-regulation of Notch scenarios. This appears to be an ongoing
response over time given that an intermediate genetic phenotype is
observed in the tailbud stage that is less severe than at the neurula stage,
but not as fully compensated as in the swimming tadpole stage.
Additionally, we set out to characterize the nature of the compensa-
tory response to identify potential mechanisms. Notch signaling is known
to regulate cell proliferation (Go et al., 1998; Roese-Koerner et al., 2017),105leading us to investigate neural cell numbers and proliferative status
throughout the compensation. While we observed initially increased
numbers of neuronal cells following Notch hyperactivation, it was
normalized by the swimming tadpole stage. However, no changes in
neuronal cell number were observed following Notch inhibition. This
could be because active Notch signaling is associated with active prolif-
eration (Grotek et al., 2013; Roese-Koerner et al., 2017). Accordingly, we
also observed increased levels of proliferation in Notch hyperactivated
embryos. After the cessation of increased proliferation, Notch hyper-
activated embryos show increased levels of apoptosis, suggesting that
this may be the mechanism utilized to normalize cell number during the
compensation. This could be similar to the endogenous requirement for
apoptosis during neural development (Offner et al., 2005; Juraver-Geslin
and Durand, 2015). Together, these data suggest that the perturbation
initially causes variations in cell number, caused by differential prolif-
eration, which is then normalized by apoptosis as the compensation
proceeds. However, it should be noted that while much of the literature
on the Notch signaling pathway in early vertebrate development focuses
on the nervous system, components of the pathway are expressed in other
embryonic tissues (Peyrot et al., 2011; Castro-Colabianchi et al., 2018).
Manipulations of the Notch pathway through constructs injected at early
G.E. Solini et al. Developmental Biology 460 (2020) 99–107cleavage stages may be affecting as well. Thus the phenotypes we observe
on neural tissue may be attributable, in part, to indirect effects exerted
from the mesoderm, endoderm, and/or ectoderm. While we controlled
for the uniform distribution of the tracer, it remains possible that ICD or
DBM RNA was not uniformly localized and may account for some of the
observed phenotypic variability.
We also tested the limits of the compensatory response and demon-
strated that embryos are unable to recover from higher doses of Notch
hyperactivation, likely due to toxicity. Embryos with global Notch
hyperactivation, in which the ICD construct is injected into both sides of
the two-cell stage embryo, did not show a compensatory response, sug-
gesting that degradation of injected RNA alone is not sufficient to explain
the observed compensation. This result also suggests that communication
between both sides of the neural plate may be playing a significant role in
the compensatory response. The possible interaction between the two
sides of the embryo suggests that the use of the uninjected side as an
internal negative control should be used with caution and comparison
with wild type uninjected embryos should be considered as well.
As a whole, the data presented here reveal that embryos compensate
for Notch signaling perturbation over time and can utilize mechanisms of
proliferation and apoptosis to recover from unilateral Notch perturba-
tion. While microarray analyses suggested that multiple components of
the network of neural patterning genes are being differentially expressed
(Vasiliu et al., 2015), further transcriptomic analyses will reveal whether
nonsense-induced transcriptional compensation (El-Brolosy et al., 2019;
Ma et al., 2019) and the activation of gene networks based on paralogous
genes are also playing a role. This work provides another model for
addressing mechanisms of genetic compensation, which could be eluci-
dated with additional mechanistic studies based on our system.Declaration of competing interest
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